Lantern Pharma (LTRN)
(Delayed Data from NSDQ)
$3.44 USD
+0.05 (1.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $3.40 -0.04 (-1.16%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | 16.36% |
ABR | NA |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.12 |
Next Year | -2.02 |
EPS (TTM) | -1.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.59 | -2.12 | -2.02 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.56 | -0.59 | -2.12 | -2.02 |
High Estimate | -0.56 | -0.59 | -2.12 | -2.02 |
Low Estimate | -0.56 | -0.59 | -2.12 | -2.02 |
Year ago EPS | -0.29 | -0.39 | -1.47 | -2.12 |
Year over Year Growth Est. | -93.10% | -51.28% | -44.22% | 4.72% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.59 | -2.12 | -2.02 |
7 Days Ago | -0.56 | -0.59 | -2.12 | -2.02 |
30 Days Ago | -0.56 | -0.59 | -2.12 | -2.02 |
60 Days Ago | -0.56 | -0.59 | -2.12 | -2.02 |
90 Days Ago | -0.57 | -0.60 | -2.23 | -2.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.59 | -2.12 | -2.02 |
Zacks Consensus Estimate | -0.56 | -0.59 | -2.12 | -2.02 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.51 | -0.39 | -0.29 | NA |
Estimate | -0.55 | -0.43 | -0.40 | -0.46 | NA |
Difference | 0.09 | -0.08 | 0.01 | 0.17 | 0.05 |
Surprise | 16.36% | -18.60% | 2.50% | 36.96% | 9.31% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more